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Skin bio psies fro m 6 pati ents with J essner's lymph ocytic 
in filtration OLl) were studied using monoclonal antibodies 
in peroxidase stainin g, on some occasions combined with 
[3H]th ymidi ne inco rpo rati on visuali zed by autoradiogra-
p hy. Nin ety-one ± two percent oLdl inAamm ato ry mono-
n uclea r cell s in situ were Tll-positive T lymph ocytes, 
w hereas B lymphocytes were few . Forty-nine ± nine per-
cent of cell s were la-pos iti ve; sugges tin g in vo lvement o f 
T cell s in the loca l pathogcncti c mechanisms, but intcrl eu-
kin-2 recepto r-ca rrying cell s as w ell as e H]th ymidin e-in-
corpo rating ce lls accounted fo r less than 2% of all inflam-
matory cell s, sugges ting that T blas ts account for onl y a 
J essner's lymphocy ti c in fIltrat io n U U ) o.fthe skin 111 was ea rlier considcrcd to be a va riant or cad y manifes tati on of disco id lupus erythcm atosus (DLE) o r po lymo rpho us li g ht erupti o n (PLE) but by so me auth o rs also as a B ccll-derived prelym-ph o matous [2 1 conditio n. Recentl y , howeve r, T cel ls have 
been shown to be predominant [3J in the infiltration. Histopath-
o logica ll y, JLI resemb les DLE and systemi c lu pus eryth ematosus 
(S LE) [1 ,4J to so me extent. T he principa l histologic dcviations 
are th e absencc o f epidcrm al in volve ment and of fo ll icular plug-
g ing . Even in ch roni c cascs of jLl o nl y a slight fl atten in g of the 
epidcrmis may be sccn, but no othcr epiderm al changes akin to 
thosc obscrved in DLE develo p [5]. N o in volvcment of intcrnal 
o rga ns typi ca l o f SLE [6J has bcen repo rtcd . To stud y JLI o f thc 
skin in more detail , we m adc a clin icopatho logic sur vey of6 10ng-
term fo llow-up pati ents. 
PAT IE NTS AND METH O DS 
Patients Six patients w ith J LI w ith 3 lo ngs tandin g histo ry were 
enroll cd in the study. T he clini ca l and labo rato ry data of thc 
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Abbreviatio ns: 
ANA E: a -naphth yl :Iccta te esterase 
D LE: di scoid lupus erythematosus 
JLI : Jessner's lymphocy ti c infi ltratio n 
PHA : ph ytohemagglutinin 
PLE: polymorphic light e ruptio n 
SLE: sys tcmic lu pus ery thcm atosus 
small minority. Similarl y, PCA-l plas ma cell s were few 
in situ , th ere was no immunoglobulin o r complement dep-
os ition at the dermal-epidermal junction and serum anti-
nuclea r and anti:-DNA antibodies as wel l as complem cnt 
levels were normal, and no visceral in vo lvement was rc-
vealed durin g the su rvey period . Accord in g to our find-
in gs, JLl of the skin seems to be suffIciently di stinctive to 
be appreciated as an entity. T lymphocytes in JLI do not 
seem to proliferate in the site of inflammation but are merely 
accumulated from the circulati on.] IIJLlcs / DcmHl/o/89:205-
208, 1987 
patients studi ed arc g ivcn in Tab le I. C lini call y th c lesio ns ap-
pea rcd as wel l-dcmarcatcd, peripherall y cxpandin g, pink o r rcd 
smoo th papules, plaq ues, o r nod ules in thc facc, ncck , arm s, chcst, 
o r back. Repcatcd se ro logic studi cs showcd no anti nu clear o r anti-
DN A antibod ies (sin!=; le-strandcd , doublc-stranded), and the scrum 
co mpl ement co mponent C3 and C4 lcve ls wcrc in a no rm al ra ngc . 
Bccau se the histo logy o f thc lcsio ns in DLE, PLE, and JLI may 
rescmble each oth cr, o ne part of thc biopsy speci mens was p ro-
ccsscd fo r ro utin e 1-1 & E staining in o rdcr to vc ri fy th e co rrcct 
di agnosis of J Ll. The routin e hi sto logy rcvcaled no rm al cp ider-
mis, w hcrcas den sc accumulations of unifo rm sm :lill ymphocytcs 
wcre occup yin g mu ch of th e dcrmis, cx tendin g occasio n31l y in to 
the subcutis. Thc infiltratcs wen:; m ostl y locatcd in th e pcrivas-
cular or periadnexal areas. Histocytc and p lasm a ccll s wcre also 
presen t in so me spccimcns. T he densities of thc ccll ul 3r infi ltrates 
of th c p3tients wcrc comparablc. All paticn ts showin g fo lli cu lar 
hypcrkcratosis o r atrophy were cxcludcd. O nl y paticnts wi th 
recurrent les io ns hca ling w itho ut scqu elac wcrc included in thc 
stud y g roup . Skin bio psics fro 111 the patients wc rc alw3Ys takcn 
fr0 111 acti vc lcsions. A part of th e biopsy spccim en was snap-
frozen in liquid nitrogen and storcd at - 70°C un til proccssing . 
Dircct immunofl uo resccncc us ing a st3 nd3rd techniquc showcd 
no deposition ofiml11l1no glo bulin o r complem ent in thc clini cally 
in volvcd skin. N o nc of the paticnts fulfill cd th e Ameri ca n Rh cu-
111 atism Associat ion 1982 cri te ri a fo r SLE 16 1. Two pat icnts C0 111-
plaincd abo ut ph otosensitivity . H owcver, pho totcstin g with 3 
supracrythcma l dosc o f UV rad iati on (Philips TL 20W /08 black 
li g ht tubes) proved no rm 31. Thc m ea n fo llow-up tim e for th e 
stud y group at th e tim e for bio psy was 7.6 yea rs (ra nge 2-15 
yca rs). D urin g th e follow-up period no transfo rm atio ns in to Iym-
pho prolifcrat ive l11~li gn a nc i cs were rcco rdcd and, in spitc of 
so mctim es extensivc lympocyti c inftltr3tcs, no gcrmin al ccnters 
wcrc o bservcd histopatho logicall y. 
LYlllpho prcp (specifi c g rav ity 1. 078 o-/ Ii ter) dcnsity g rad icnt 
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Table I. The C linical and Laboratory Data of the Patients Studied 
Age at Time Duration Localization 
Pt. of First of the the Skin SR Hb C3 C4 Treatment at 
No Examination Disease Lesions (n1ln /h) (glliter) ANA a-DNA (g/Iiter) (g/ Iiter) IF Time of biopsy 
35 years 9 years Face, ears, 9 139 Neg Neg 0.66 0.23 Neg None 
back 
2 27 years 15 years Chest, neck 4 142 ND ND ND ND Neg None 
3 32 years 12 years Back, arms 16 126 Neg Neg 0.93 0.3 \ Neg Chloroquine. 
proquazone 
4 55 years 3 years Neck. back 24 137 Neg Neg NO ND Neg None 
5 44 years 2 years Face 5 153 Neg Neg 0.73 0.24 Neg None 
6 36 years 5 years Chest. neck 8 155 Neg NO 0.84 0.21 Neg None 
Abbreviations: sa = erythrocyte sedimentation ratc. Hb = serum hemoglobin concentration, ANA; antinuclear antibodies, a-DNA ; anti-deoxyribonucleic acid 
an tibodies, C3 = serum complement 3 (normal 0.55- 1. 20) , C4 ; serum complement 4 (normal 0.20-0.50), IF = immunofluorescence, NO = not done. 
isolation (350 g. 40 min , + 22°q was used to obtain peripheral 
blood mononuclear cells from heparinized venous blood diluted 
1:1 with RPMI 1640 from 4 patients withJLI and from 4 normal 
healthy controls. The cells were washed, and cytospin prepara-
tions (1 X 105 cells/slide) were made and air-dried before sub-
sequent immunostaining . 
ltnmunohistochemistry Immediately after remova l, punch 
biopsy samples 3-4 mm in diameter were put in RPMI 1640 
solution containing 3 p,Ci/ml of [3H]thymidine (5 mCi/mmol; 
Radiochemical Centre, Amersham, U .K.), incubated for 4 h at 
+ 37°C in 5% CO2-in-air [7], and then embedded and frozen in 
OCT compound (Lab-Tek Products, Division of Miles Labo-
ratories, Naperville, Illinois) . 
For immunostaining [8] cryostat sections 6 p,m thick were pre-
pared and (1) fixed in cold (+ 4°q acetone for 5 min . (2) The 
endogenous peroxidase activity was blocked with 0.3% H20 2 for 
15 min and then the sections were treated with (3) normal horse 
serum (1;5, Orion Pharmaceuticals, Helsinki, Finland) for 20 min, 
(4) mouse monoclonal antibody (1:10-1:50, OKT11, OKT4, 
OKT8, OKM1, OKla, OKT9 from Ortho Diagnostic System 
Inc., Raritan, New Jersey; 1 :50, pan-B from Dakopatts, Copen-
hagen, Denmark; 1:50, PCA-l from Coulter Immunology, Hi-
aleah, Florida; 1 :1000, anti-Tac was generously provided by Prof. 
Thomas Waldmann, Metabolism Branch, National Institutes of 
Health, Bethesda, Maryland; and 1 :5000, anti-4F2 by Prof. An-
thony Fauci, Laboratory of Clinical Investiga tion , N ational In-
stitutes of Health, Bethesda, Maryland) for 60 min, (5) biotiny-
lated horse antimouse antibody (the ABC kit from Vector 
Laboratories, Burlingame, California) for 30 min and (6) avidin-
biotin-peroxidase complex for 30 min . Finally, (7) the sites of 
peroxidase binding were revealed with 3,3' -diaminobenzidine tet-
rahydrochloride (Sigma Chemical Co., St. Louis, Missouri) be-
fore (8) counterstaining in hematoxylin . Between each step slides 
were washed twice in phosphate-buffered saline (0.1 M, pH 7.3). 
The staining controls used were (1) omission of the primary 
monoclonal antibody in the staining sequence, and (2) use of 
inappropriate antibodies in the second stage (e.g., biotinylated 
goat antirabbit IgG). 
The slide controls for activation marker analysis were stained 
in parallel with the specimen under study. They were: (1) non-
stimulated Ficoll-Hypaque isolated, plastic adherence depleted pe-
ripheral blood lymphocytes as "negative controls," and (2) phy-
tohemagglutinin (PHA; 1 p,g/ml)-stimulated peripheral blood 
mononuclear cells as "positive controls." Nonstimulated periph-
eral blood lymphocytes from 3 healthy volunteers all had <5% 
of la +, Tac+, T9 +, and 4F2 + cells, whereas on stimulation day 
3, 23 ± 2%, 75 ± 11 %, 68 ± 18%, and 63 ± 6% of all PHA-
stimulated lymphocytes were la +, Tac+, T9 +, and 4F2 +, re-
spectively . 
Autoradiography The slides stained for Tll, pan-B, and PCA-
1 were further processed for autoradiography [7] before mount-
ing. They were dipped in NTB2 nuclear track emulsion (Eastman 
Kodak Co., Rochester, New Yo rk) , exposed in darkness at + 4°C 
for 7 days, developed (Rodinal; Agfa-Gevaert, Leverkusen, ,,(est 
Germany), and fixed (Rapid Fix, Agfa-Gevaert) before mounnng. 
Evaluation of the Results Exogenous peroxidase-positive, 
specifically stained cells were brown and thus readily distingUish-
able from unstained cells under a light microscope. Cells were 
regarded as [3HJthymidine labeled when they contained > 10 
grains over the cell nucleus. The number of cells analyzed by 
light microscopy was counted usin g an ocular counting square 
(20 squares x 20 squares) and an oil immersion lense (1000 X 
magnification). Standard error of the mean was uSf'd to express 
dispersion. 
RESULTS 
The staining and slide controls showed the speciftcity of the stain-
ing, demonstrating that the inhibition of endogenous peroxidase 
was successful. . 
Most of the local lymphocyte infiltrates were located around 
postcapillary venules and consisted mainly ofT lymphocytes. T 
cells outnumbered the T4 cells in local lymphocytic inftltrare 
with T4/T3 ratio of 0.9 ± 0.1. B lymphocy tes and plasma cells 
were few in situ (Fig 1). 
Although the proportion of major histocompatibility complex 
locus II coded Ia-antigen-positive cells was hi gh in perivascular 
lymphocy tic infiltrates (49 ± 9%) (Fig 1) , there were only few 
(0.5 ± 0.1 %) Tac-positive cells carrying interleukin-2 receptor 
(Fig 2a,b). The proportion ofT9-positive cells carrying transferrin 
receptor as well as 4F2-positive cells carrying glyco protein 40/80 
was slightly higher (Table II) . Most of the endothelial cells in the 
middle of the perivascu lar infiltrates were also la-positive. 
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Figure 1. Histogram of the proportions of positively staining cells inJU 
of the skin. Monoclonal antibodies used for staining are indicated on th 
x-axIs. 
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The relatively low proportion of cells in situ expressing im-
m unoreactive interleukin-2 receptor mi ght have been due to 
blocking caused by receptor-bound interleukin 2. Beca use this 
should push the cells over the G1/S interphase, we studied the 
proportion of T cells synthetizing DNA in situ . However, only 
occasional [3H]thymidine-incorporating T blasts were observed 
in situ (Fig 3), suggesting that the low proportion of T cells 
carrying interleukin-2 receptor is no t an artifact. The double la-
beling technique also showed that the m ajo rity of these T blas ts 
carried the T4 glycoprotein . 
DISCUSSION 
Only occassional PCA-1 plasma cells were observed in JLI of the 
skin . There were no immunoglobulin o r complement deposits at 
the dermal-epidermal junction either [9, 10] . N one of our patients 
during the follo w-up developed any systemic symptoms or vis-
ceral invol vement akin to those observed in SLE. Thus, there is 
little evidence for active involvem ent of B cell-mediated humoral 
immune response in the pathogenesis of JLI o f the skin . 
Some authors have class ified JLI of the skin as a pseudolym-
phom a consisting exclusively of B lymphocytes [2]. However, 
according to our findings most of the mononuclear inflammatory 
cells do not carry m arkers typical of resting B lym phocytes o r 
plasm a cells but display T-l ymphocy te markers . None of Our 
patients developed a lymphoproliferative malignancy either. These 
findings refute the idea of JLI as a B cell-derived prelympho-
matous condition. 
We have previously reported, using histochemical a-naphthyl 
acetate esterase (AN AE) staining, that most of the inflammatory 
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Figure 2. n, A relatively large propor-
tion of the lymphocytes in situ were la-
positive in avidin-biotin-peroxidase 
complex staining. Because resting pe-
ripheral blood T lymphocytes do not ex-
press la, this suggests T-cell involve-
ment in the local pathogenetic 
mechanisms. Orig inal magnification x 
400. b, The same infi ltrate as in (0) is 
shown after avidin-biotin-peroxidase 
complex staining using monoclonal Tac 
antibodies . O nly occasional interl eukin-
2 receptor-carrying lymphocytes were 
observed in situ in JLI of the skin, sug-
ges ting that these infiltrates contain only 
a few T blasts. 
cells in JLI belong to the T-cell series [4] . This was confi rmed by 
Willemze et al [3] w ho used T cell-specific m onoclonal antibodies. 
They further proposed JLI of the skin to be not a B-cell but a T-
cell lym phoproliferative disease. Based on histochemical AN.'1E 
staining, however, this seems improbable: although resting T 
lymphocytes display ANAE [11], T blas ts do no t [12]. Our pres-
ent results on low interleukin-2 recepto r expression as well as the 
low proportion of DNA-synthesizing T cells in si tu further sug-
gest that JLI is no t a local T-cell lym phoproliferative disease . 
As for the activation of T cell-mediated cellular response, our 
findings show a high proportion of Ia (HLA-DR)-positive cells 
in the lymphocytic infil trate around postcapillary venules, quite 
different from that reported by Willemze et al [13], who co uld 
not find any la- positive cells in JLI. Several previous studies ha ve 
shown that the local lymphocytes in va rious disease conditions 
characterized by mononuclear cell infiltra tes are ac tive participants 
in the local pathogenetic mechanism s based on the relatively high 
expression of la antigen [14] . However, recent studies comparing 
in vitro an d in vivo ac tivated lymphocytes have shown that most 
of the in vi tro activa ted la-positive T lymphocytes are blas t cells, 
w hereas most of the in vivo activated T lymphocytes are small 
lymphocytes [15]. This may also explain our own observation of 
a high proportion of la-posi tive but a low proportion of Tac-
positive and proliferating T cells. As fo r the role ofI a on T cells, 
it might be associated with lymphocyte homing receptors [1 6] 
responsible for their interaction with the hi gh endo thelial cel ls 
and thus their accumulation into inflammation sites . This is sup-
ported by our finding that most of the endothelial cells in the 
middl e of the inflammato ry perivascular infiltrations were also 
Table II. Comparison of the M ononuclear Cell Phenotypes Between Jessner 's Lymphocytic Infiltration OLI) and Peripheral 
Blood (PB) of the Patients (% ± SEM) 
TIl T4 T8 MI B la Tac T9 4F2 
Tissues 91 ± 2" 40 ± 3 49 ± 4" 5 ± I" 2 ± 0.3 49 ± 9" 0.5 ± 0.1 7 ± 2" 10 ± 2" 
PB of the 77 ± 2 48 ± 3 29 ± 4 22 ± 2 2 ± 0.4 4 ± 1 0.6 ± 0.2 0.8 ± 0.2 3 ± 1 
patients 
PB of the 72 ± 4 47 ± 4 25 ± 1 17 ± 3 3 ± 1 3 ± 0.2 0.2 ± 0. 1 0.4 ± 0. 1 2 ± 0. 1 
controls 
' p .. 0.0 1 (Mann-Whitney test) ; there were nO signifi ca nt differences between the PB of JLI pa tients and normal hea lth y co ntro ls. 
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Figure 3. The low proportion of int~ r­
leukin-2 recep to r-ca rrying lymphocytes 
might have been due to the blocking of 
immunoreactivc epitopes by receptor-
bo und interl eukin 2. This was rcfuted 
by [3H1thymidinc incorporation/auto-
radiography combined with T-cell sta in-
ing using T11 antibodies in av idin-bio-
tin-peroxidase complex staining: in spitc 
of good penetration of [OH]th ymidine 
(prolifcrating epidermal basal cells are 
marked w ith large arrows), onl y occa-
sional [3H]thymidine-incorporating T 
blasts (slI1all arrows) were obscrved in situ. 
Original magnifica tion x 400. 
1I'!i""» 
la-positive. However , the exact relationship of 13 and Herm es-1 
(involved in high endothelial venule recognition) expression dur-
ing different phases of the T-cell cycle is no t yet known [1 6]. 
Upon activation, durin g the G I phase of the ccll cycl e T lym-
phocytes acquire interl eukin-2 receptor on their surface [171. In 
the presence of interleukin 2, a soluble T-cel l growth factor , these 
activate~ T cells will be further pushed into th e S phase of the 
cell cycle. The number of cells in th e S phase of the cell cycle 
was low based on a double labeling technique co mbining auto-
radiography with immunoperoxidase staining. The scarcity of 
[3H]thymidine incorporating blasts confirms the impression o b-
tained usin g analysis of interleukin-2 receptor expression. It also 
suggests that the low interleukin-2 receptor ex pression observed 
in situ is not due to blocking of the receptors by receptor-bo und 
interleukin 2. 
Our findings suggest that , although the diagnosis of JLI of the 
skin ca nnot be mad e on the basis of any single clini cal or histo-
pathologic observation , so me cases in a long-term follow-up see m 
to be sufficiently distinctive to be regarded as a separate di sease 
entity . We did not find evidence of activation of the B cell-me-
diated humoral arm in this disease, and the loca l T cells , although 
la- positive, did not display interlcukin-2 receptor and, accord-
ingly, only 3 few DNA-synthetizing blasts were present in situ. 
Til e alltllors nrc illdebted to (lI e skilljili (ec/mien l assistall ce oj L. Jaakkola, B.A. 
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